London-based Samphire Neuroscience raises €2.1 million to launch wearable that targets PMS and menstrual pain

London-based Samphire Neuroscience raises €2.1 million to launch wearable that targets PMS and menstrual pain Medtech startup Samphire Neuroscience secured €2.1 million in pre-seed funding to launch Nettle, their medical-grade neurostimulation wearable. Read the article on EU Startups > Read More from the Global Wellness News ™

The Trend in the News: A Wellness Check for Weight Loss Drugs in 2024

Trend: A Wellness Check for Weight Loss Drugs in 2024 Week of Feb 21st, 2024 The Race Is on to Stop Ozempic Muscle Loss–The New York Times, February 8, 2024  A great overview of how fitness brands, nutrition startups, and drugmakers all want to solve a common issue with weight loss drugs: significant muscle loss that can happen. Luxury gyms are offering strength-training programs specifically marketed…